CELL SIGNAL 润色咨询

CELLULAR SIGNALLING

出版年份：1989 年文章数：3025 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：2.5% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2145528, encodeId=bbb0214552839, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：癌症;LncRNA;机制研究<br>经验分享：期刊效率非常快，送审时邀请了四位审稿人，不到二十天就收到了三个审稿人的意见，加起来比较多，算是大修，让补一些实验，不过我没有都补完。大修给了返修时间是两个月，我是卡点最后一天修回的，十二天后收到了接收的好消息。总的来说，期刊的编辑很负责，效率很高，建议做分子机制研究的可以试一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e68203665, createdName=ms3000001479435505, createdTime=Thu Jun 29 21:02:28 CST 2023, time=2023-06-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2153895, encodeId=19632153895ba, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：耐药<br>经验分享：新鲜出炉的投稿数据分享：<br>6-20投稿，<br>6-29大修，两个审稿人，提了20个问题，需要补实验，给2个月时间大修<br>8-08修回<br>8-21接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Mon Aug 21 17:00:18 CST 2023, time=2023-08-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2129105, encodeId=4d6a212910559, content=请问这篇期刊需要WB未裁剪的膜吗？需要三次数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c1e6397195, createdName=ms1000000465565248, createdTime=Fri Apr 28 20:58:27 CST 2023, time=2023-04-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2130296, encodeId=06a021302968c, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：长链非编码RNA;胃癌<br>经验分享：2023.01.22投稿，2023.2.21三个审稿人大修，其中第一第二个审稿人意见较多，第三个建议修改语言后接收，2023.3.13修回，2023.4.01小修只剩2个审稿人，第一个审稿人跑路，第二审稿人重复提问第一次的三个问题，第三个审稿人建议直接接收，2023.4.12修回，第三个审稿人两三天就上传意见了，第二个审稿人倒是很快同意审稿，但是就不上传意见，至今已经23天了，还在Under reviewer。第二个伊朗的审稿人，一审1个月，二审拖我3周，三审还在拖我。从第一稿开始要求我引用三篇他自己一两分的文章，而且方向根本不符，一直在拖延一直拖延，我搞不明白这是伊朗审稿人的作风吗？我承认自己文章水，但是碰见这样的审稿人真是让人抓狂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f148262722, createdName=ms1000002048633462, createdTime=Fri May 05 18:17:38 CST 2023, time=2023-05-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2152810, encodeId=6bac215281005, content=偏重的研究方向：肿瘤;信号通路<br>经验分享：打卡 23.8.15投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Tue Aug 15 08:45:04 CST 2023, time=2023-08-15, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2120005, encodeId=78892120005f8, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：细胞生物学;基础研究;细胞信号转导<br>经验分享：2022.12.31 投稿 2023.1.21 大修 给了两个月 2023.3.16 12:00 提交返修稿 2023.3.16 17:00 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210411/da80771de7994056b41a9cf7d83c2962/5ab66ed7d0ad45638a7838a3990b1120.jpg, createdBy=97072405099, createdName=12362864m67暂无昵称, createdTime=Thu Mar 16 18:58:49 CST 2023, time=2023-03-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2139426, encodeId=1f102139426f2, content=审稿速度:6.0 | 投稿命中率:5.0<br>经验分享：大神...我被拒三次了。两次是直接拒，还有一篇是大修后拒绝了。<br>感觉该刊水平很高，特别对文章的布局和逻辑性要求很严格，对文字和图片要求也较高。个人认为比较难投，看来我们团队仍需继续努力，争取中一篇!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eobiabkoCXUvOBNyXMalKS3zXem2O3LBjDlmjoq64XhEZBxFyhv1CxL9tlviaMa9okUyKD6iblpiamoDg/132, createdBy=8e402293681, createdName=ms9694374296529568, createdTime=Sat May 27 21:33:31 CST 2023, time=2023-05-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2133876, encodeId=910921338e662, content=杂志官网公布的时间不到一个月。但是我返修目前已经一个月了，还是Under Review？这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c755527092, createdName=smf1993428, createdTime=Mon May 15 10:38:44 CST 2023, time=2023-05-15, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2122806, encodeId=1e5621228066f, content=投稿一个多月，告诉我找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d115608144, createdName=ms2000000959270113, createdTime=Thu Mar 30 19:22:37 CST 2023, time=2023-03-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093349, encodeId=4e632093349e1, content=请问一般with editor多久啊？都一周了还没有消息？会不会被拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b058356108, createdName=ms1000000391690108, createdTime=Wed Oct 12 11:14:27 CST 2022, time=2022-10-12, status=1, ipAttribution=)]
    2023-06-29 ms3000001479435505 来自江苏省

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向：癌症;LncRNA;机制研究
    经验分享：期刊效率非常快，送审时邀请了四位审稿人，不到二十天就收到了三个审稿人的意见，加起来比较多，算是大修，让补一些实验，不过我没有都补完。大修给了返修时间是两个月，我是卡点最后一天修回的，十二天后收到了接收的好消息。总的来说，期刊的编辑很负责，效率很高，建议做分子机制研究的可以试一试。

    4

    展开4条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2145528, encodeId=bbb0214552839, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：癌症;LncRNA;机制研究<br>经验分享：期刊效率非常快，送审时邀请了四位审稿人，不到二十天就收到了三个审稿人的意见，加起来比较多，算是大修，让补一些实验，不过我没有都补完。大修给了返修时间是两个月，我是卡点最后一天修回的，十二天后收到了接收的好消息。总的来说，期刊的编辑很负责，效率很高，建议做分子机制研究的可以试一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e68203665, createdName=ms3000001479435505, createdTime=Thu Jun 29 21:02:28 CST 2023, time=2023-06-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2153895, encodeId=19632153895ba, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：耐药<br>经验分享：新鲜出炉的投稿数据分享：<br>6-20投稿，<br>6-29大修，两个审稿人，提了20个问题，需要补实验，给2个月时间大修<br>8-08修回<br>8-21接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Mon Aug 21 17:00:18 CST 2023, time=2023-08-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2129105, encodeId=4d6a212910559, content=请问这篇期刊需要WB未裁剪的膜吗？需要三次数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c1e6397195, createdName=ms1000000465565248, createdTime=Fri Apr 28 20:58:27 CST 2023, time=2023-04-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2130296, encodeId=06a021302968c, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：长链非编码RNA;胃癌<br>经验分享：2023.01.22投稿，2023.2.21三个审稿人大修，其中第一第二个审稿人意见较多，第三个建议修改语言后接收，2023.3.13修回，2023.4.01小修只剩2个审稿人，第一个审稿人跑路，第二审稿人重复提问第一次的三个问题，第三个审稿人建议直接接收，2023.4.12修回，第三个审稿人两三天就上传意见了，第二个审稿人倒是很快同意审稿，但是就不上传意见，至今已经23天了，还在Under reviewer。第二个伊朗的审稿人，一审1个月，二审拖我3周，三审还在拖我。从第一稿开始要求我引用三篇他自己一两分的文章，而且方向根本不符，一直在拖延一直拖延，我搞不明白这是伊朗审稿人的作风吗？我承认自己文章水，但是碰见这样的审稿人真是让人抓狂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f148262722, createdName=ms1000002048633462, createdTime=Fri May 05 18:17:38 CST 2023, time=2023-05-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2152810, encodeId=6bac215281005, content=偏重的研究方向：肿瘤;信号通路<br>经验分享：打卡 23.8.15投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Tue Aug 15 08:45:04 CST 2023, time=2023-08-15, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2120005, encodeId=78892120005f8, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：细胞生物学;基础研究;细胞信号转导<br>经验分享：2022.12.31 投稿 2023.1.21 大修 给了两个月 2023.3.16 12:00 提交返修稿 2023.3.16 17:00 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210411/da80771de7994056b41a9cf7d83c2962/5ab66ed7d0ad45638a7838a3990b1120.jpg, createdBy=97072405099, createdName=12362864m67暂无昵称, createdTime=Thu Mar 16 18:58:49 CST 2023, time=2023-03-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2139426, encodeId=1f102139426f2, content=审稿速度:6.0 | 投稿命中率:5.0<br>经验分享：大神...我被拒三次了。两次是直接拒，还有一篇是大修后拒绝了。<br>感觉该刊水平很高，特别对文章的布局和逻辑性要求很严格，对文字和图片要求也较高。个人认为比较难投，看来我们团队仍需继续努力，争取中一篇!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eobiabkoCXUvOBNyXMalKS3zXem2O3LBjDlmjoq64XhEZBxFyhv1CxL9tlviaMa9okUyKD6iblpiamoDg/132, createdBy=8e402293681, createdName=ms9694374296529568, createdTime=Sat May 27 21:33:31 CST 2023, time=2023-05-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2133876, encodeId=910921338e662, content=杂志官网公布的时间不到一个月。但是我返修目前已经一个月了，还是Under Review？这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c755527092, createdName=smf1993428, createdTime=Mon May 15 10:38:44 CST 2023, time=2023-05-15, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2122806, encodeId=1e5621228066f, content=投稿一个多月，告诉我找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d115608144, createdName=ms2000000959270113, createdTime=Thu Mar 30 19:22:37 CST 2023, time=2023-03-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093349, encodeId=4e632093349e1, content=请问一般with editor多久啊？都一周了还没有消息？会不会被拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b058356108, createdName=ms1000000391690108, createdTime=Wed Oct 12 11:14:27 CST 2022, time=2022-10-12, status=1, ipAttribution=)]
    2023-08-21 1891e859aem 来自广东省

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向：耐药
    经验分享：新鲜出炉的投稿数据分享：
    6-20投稿，
    6-29大修，两个审稿人，提了20个问题，需要补实验，给2个月时间大修
    8-08修回
    8-21接收

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2145528, encodeId=bbb0214552839, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：癌症;LncRNA;机制研究<br>经验分享：期刊效率非常快，送审时邀请了四位审稿人，不到二十天就收到了三个审稿人的意见，加起来比较多，算是大修，让补一些实验，不过我没有都补完。大修给了返修时间是两个月，我是卡点最后一天修回的，十二天后收到了接收的好消息。总的来说，期刊的编辑很负责，效率很高，建议做分子机制研究的可以试一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e68203665, createdName=ms3000001479435505, createdTime=Thu Jun 29 21:02:28 CST 2023, time=2023-06-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2153895, encodeId=19632153895ba, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：耐药<br>经验分享：新鲜出炉的投稿数据分享：<br>6-20投稿，<br>6-29大修，两个审稿人，提了20个问题，需要补实验，给2个月时间大修<br>8-08修回<br>8-21接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Mon Aug 21 17:00:18 CST 2023, time=2023-08-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2129105, encodeId=4d6a212910559, content=请问这篇期刊需要WB未裁剪的膜吗？需要三次数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c1e6397195, createdName=ms1000000465565248, createdTime=Fri Apr 28 20:58:27 CST 2023, time=2023-04-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2130296, encodeId=06a021302968c, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：长链非编码RNA;胃癌<br>经验分享：2023.01.22投稿，2023.2.21三个审稿人大修，其中第一第二个审稿人意见较多，第三个建议修改语言后接收，2023.3.13修回，2023.4.01小修只剩2个审稿人，第一个审稿人跑路，第二审稿人重复提问第一次的三个问题，第三个审稿人建议直接接收，2023.4.12修回，第三个审稿人两三天就上传意见了，第二个审稿人倒是很快同意审稿，但是就不上传意见，至今已经23天了，还在Under reviewer。第二个伊朗的审稿人，一审1个月，二审拖我3周，三审还在拖我。从第一稿开始要求我引用三篇他自己一两分的文章，而且方向根本不符，一直在拖延一直拖延，我搞不明白这是伊朗审稿人的作风吗？我承认自己文章水，但是碰见这样的审稿人真是让人抓狂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f148262722, createdName=ms1000002048633462, createdTime=Fri May 05 18:17:38 CST 2023, time=2023-05-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2152810, encodeId=6bac215281005, content=偏重的研究方向：肿瘤;信号通路<br>经验分享：打卡 23.8.15投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Tue Aug 15 08:45:04 CST 2023, time=2023-08-15, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2120005, encodeId=78892120005f8, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：细胞生物学;基础研究;细胞信号转导<br>经验分享：2022.12.31 投稿 2023.1.21 大修 给了两个月 2023.3.16 12:00 提交返修稿 2023.3.16 17:00 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210411/da80771de7994056b41a9cf7d83c2962/5ab66ed7d0ad45638a7838a3990b1120.jpg, createdBy=97072405099, createdName=12362864m67暂无昵称, createdTime=Thu Mar 16 18:58:49 CST 2023, time=2023-03-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2139426, encodeId=1f102139426f2, content=审稿速度:6.0 | 投稿命中率:5.0<br>经验分享：大神...我被拒三次了。两次是直接拒，还有一篇是大修后拒绝了。<br>感觉该刊水平很高，特别对文章的布局和逻辑性要求很严格，对文字和图片要求也较高。个人认为比较难投，看来我们团队仍需继续努力，争取中一篇!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eobiabkoCXUvOBNyXMalKS3zXem2O3LBjDlmjoq64XhEZBxFyhv1CxL9tlviaMa9okUyKD6iblpiamoDg/132, createdBy=8e402293681, createdName=ms9694374296529568, createdTime=Sat May 27 21:33:31 CST 2023, time=2023-05-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2133876, encodeId=910921338e662, content=杂志官网公布的时间不到一个月。但是我返修目前已经一个月了，还是Under Review？这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c755527092, createdName=smf1993428, createdTime=Mon May 15 10:38:44 CST 2023, time=2023-05-15, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2122806, encodeId=1e5621228066f, content=投稿一个多月，告诉我找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d115608144, createdName=ms2000000959270113, createdTime=Thu Mar 30 19:22:37 CST 2023, time=2023-03-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093349, encodeId=4e632093349e1, content=请问一般with editor多久啊？都一周了还没有消息？会不会被拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b058356108, createdName=ms1000000391690108, createdTime=Wed Oct 12 11:14:27 CST 2022, time=2022-10-12, status=1, ipAttribution=)]
    2023-04-28 ms1000000465565248 来自江苏省

    请问这篇期刊需要WB未裁剪的膜吗？需要三次数据吗？

    6

    展开6条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2145528, encodeId=bbb0214552839, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：癌症;LncRNA;机制研究<br>经验分享：期刊效率非常快，送审时邀请了四位审稿人，不到二十天就收到了三个审稿人的意见，加起来比较多，算是大修，让补一些实验，不过我没有都补完。大修给了返修时间是两个月，我是卡点最后一天修回的，十二天后收到了接收的好消息。总的来说，期刊的编辑很负责，效率很高，建议做分子机制研究的可以试一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e68203665, createdName=ms3000001479435505, createdTime=Thu Jun 29 21:02:28 CST 2023, time=2023-06-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2153895, encodeId=19632153895ba, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：耐药<br>经验分享：新鲜出炉的投稿数据分享：<br>6-20投稿，<br>6-29大修，两个审稿人，提了20个问题，需要补实验，给2个月时间大修<br>8-08修回<br>8-21接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Mon Aug 21 17:00:18 CST 2023, time=2023-08-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2129105, encodeId=4d6a212910559, content=请问这篇期刊需要WB未裁剪的膜吗？需要三次数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c1e6397195, createdName=ms1000000465565248, createdTime=Fri Apr 28 20:58:27 CST 2023, time=2023-04-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2130296, encodeId=06a021302968c, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：长链非编码RNA;胃癌<br>经验分享：2023.01.22投稿，2023.2.21三个审稿人大修，其中第一第二个审稿人意见较多，第三个建议修改语言后接收，2023.3.13修回，2023.4.01小修只剩2个审稿人，第一个审稿人跑路，第二审稿人重复提问第一次的三个问题，第三个审稿人建议直接接收，2023.4.12修回，第三个审稿人两三天就上传意见了，第二个审稿人倒是很快同意审稿，但是就不上传意见，至今已经23天了，还在Under reviewer。第二个伊朗的审稿人，一审1个月，二审拖我3周，三审还在拖我。从第一稿开始要求我引用三篇他自己一两分的文章，而且方向根本不符，一直在拖延一直拖延，我搞不明白这是伊朗审稿人的作风吗？我承认自己文章水，但是碰见这样的审稿人真是让人抓狂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f148262722, createdName=ms1000002048633462, createdTime=Fri May 05 18:17:38 CST 2023, time=2023-05-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2152810, encodeId=6bac215281005, content=偏重的研究方向：肿瘤;信号通路<br>经验分享：打卡 23.8.15投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Tue Aug 15 08:45:04 CST 2023, time=2023-08-15, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2120005, encodeId=78892120005f8, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：细胞生物学;基础研究;细胞信号转导<br>经验分享：2022.12.31 投稿 2023.1.21 大修 给了两个月 2023.3.16 12:00 提交返修稿 2023.3.16 17:00 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210411/da80771de7994056b41a9cf7d83c2962/5ab66ed7d0ad45638a7838a3990b1120.jpg, createdBy=97072405099, createdName=12362864m67暂无昵称, createdTime=Thu Mar 16 18:58:49 CST 2023, time=2023-03-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2139426, encodeId=1f102139426f2, content=审稿速度:6.0 | 投稿命中率:5.0<br>经验分享：大神...我被拒三次了。两次是直接拒，还有一篇是大修后拒绝了。<br>感觉该刊水平很高，特别对文章的布局和逻辑性要求很严格，对文字和图片要求也较高。个人认为比较难投，看来我们团队仍需继续努力，争取中一篇!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eobiabkoCXUvOBNyXMalKS3zXem2O3LBjDlmjoq64XhEZBxFyhv1CxL9tlviaMa9okUyKD6iblpiamoDg/132, createdBy=8e402293681, createdName=ms9694374296529568, createdTime=Sat May 27 21:33:31 CST 2023, time=2023-05-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2133876, encodeId=910921338e662, content=杂志官网公布的时间不到一个月。但是我返修目前已经一个月了，还是Under Review？这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c755527092, createdName=smf1993428, createdTime=Mon May 15 10:38:44 CST 2023, time=2023-05-15, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2122806, encodeId=1e5621228066f, content=投稿一个多月，告诉我找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d115608144, createdName=ms2000000959270113, createdTime=Thu Mar 30 19:22:37 CST 2023, time=2023-03-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093349, encodeId=4e632093349e1, content=请问一般with editor多久啊？都一周了还没有消息？会不会被拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b058356108, createdName=ms1000000391690108, createdTime=Wed Oct 12 11:14:27 CST 2022, time=2022-10-12, status=1, ipAttribution=)]
    2023-05-05 ms1000002048633462 来自广东省

    审稿速度:6.0 | 投稿命中率:75.0
    偏重的研究方向：长链非编码RNA;胃癌
    经验分享：2023.01.22投稿，2023.2.21三个审稿人大修，其中第一第二个审稿人意见较多，第三个建议修改语言后接收，2023.3.13修回，2023.4.01小修只剩2个审稿人，第一个审稿人跑路，第二审稿人重复提问第一次的三个问题，第三个审稿人建议直接接收，2023.4.12修回，第三个审稿人两三天就上传意见了，第二个审稿人倒是很快同意审稿，但是就不上传意见，至今已经23天了，还在Under reviewer。第二个伊朗的审稿人，一审1个月，二审拖我3周，三审还在拖我。从第一稿开始要求我引用三篇他自己一两分的文章，而且方向根本不符，一直在拖延一直拖延，我搞不明白这是伊朗审稿人的作风吗？我承认自己文章水，但是碰见这样的审稿人真是让人抓狂

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2145528, encodeId=bbb0214552839, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：癌症;LncRNA;机制研究<br>经验分享：期刊效率非常快，送审时邀请了四位审稿人，不到二十天就收到了三个审稿人的意见，加起来比较多，算是大修，让补一些实验，不过我没有都补完。大修给了返修时间是两个月，我是卡点最后一天修回的，十二天后收到了接收的好消息。总的来说，期刊的编辑很负责，效率很高，建议做分子机制研究的可以试一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e68203665, createdName=ms3000001479435505, createdTime=Thu Jun 29 21:02:28 CST 2023, time=2023-06-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2153895, encodeId=19632153895ba, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：耐药<br>经验分享：新鲜出炉的投稿数据分享：<br>6-20投稿，<br>6-29大修，两个审稿人，提了20个问题，需要补实验，给2个月时间大修<br>8-08修回<br>8-21接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Mon Aug 21 17:00:18 CST 2023, time=2023-08-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2129105, encodeId=4d6a212910559, content=请问这篇期刊需要WB未裁剪的膜吗？需要三次数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c1e6397195, createdName=ms1000000465565248, createdTime=Fri Apr 28 20:58:27 CST 2023, time=2023-04-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2130296, encodeId=06a021302968c, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：长链非编码RNA;胃癌<br>经验分享：2023.01.22投稿，2023.2.21三个审稿人大修，其中第一第二个审稿人意见较多，第三个建议修改语言后接收，2023.3.13修回，2023.4.01小修只剩2个审稿人，第一个审稿人跑路，第二审稿人重复提问第一次的三个问题，第三个审稿人建议直接接收，2023.4.12修回，第三个审稿人两三天就上传意见了，第二个审稿人倒是很快同意审稿，但是就不上传意见，至今已经23天了，还在Under reviewer。第二个伊朗的审稿人，一审1个月，二审拖我3周，三审还在拖我。从第一稿开始要求我引用三篇他自己一两分的文章，而且方向根本不符，一直在拖延一直拖延，我搞不明白这是伊朗审稿人的作风吗？我承认自己文章水，但是碰见这样的审稿人真是让人抓狂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f148262722, createdName=ms1000002048633462, createdTime=Fri May 05 18:17:38 CST 2023, time=2023-05-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2152810, encodeId=6bac215281005, content=偏重的研究方向：肿瘤;信号通路<br>经验分享：打卡 23.8.15投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Tue Aug 15 08:45:04 CST 2023, time=2023-08-15, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2120005, encodeId=78892120005f8, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：细胞生物学;基础研究;细胞信号转导<br>经验分享：2022.12.31 投稿 2023.1.21 大修 给了两个月 2023.3.16 12:00 提交返修稿 2023.3.16 17:00 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210411/da80771de7994056b41a9cf7d83c2962/5ab66ed7d0ad45638a7838a3990b1120.jpg, createdBy=97072405099, createdName=12362864m67暂无昵称, createdTime=Thu Mar 16 18:58:49 CST 2023, time=2023-03-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2139426, encodeId=1f102139426f2, content=审稿速度:6.0 | 投稿命中率:5.0<br>经验分享：大神...我被拒三次了。两次是直接拒，还有一篇是大修后拒绝了。<br>感觉该刊水平很高，特别对文章的布局和逻辑性要求很严格，对文字和图片要求也较高。个人认为比较难投，看来我们团队仍需继续努力，争取中一篇!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eobiabkoCXUvOBNyXMalKS3zXem2O3LBjDlmjoq64XhEZBxFyhv1CxL9tlviaMa9okUyKD6iblpiamoDg/132, createdBy=8e402293681, createdName=ms9694374296529568, createdTime=Sat May 27 21:33:31 CST 2023, time=2023-05-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2133876, encodeId=910921338e662, content=杂志官网公布的时间不到一个月。但是我返修目前已经一个月了，还是Under Review？这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c755527092, createdName=smf1993428, createdTime=Mon May 15 10:38:44 CST 2023, time=2023-05-15, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2122806, encodeId=1e5621228066f, content=投稿一个多月，告诉我找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d115608144, createdName=ms2000000959270113, createdTime=Thu Mar 30 19:22:37 CST 2023, time=2023-03-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093349, encodeId=4e632093349e1, content=请问一般with editor多久啊？都一周了还没有消息？会不会被拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b058356108, createdName=ms1000000391690108, createdTime=Wed Oct 12 11:14:27 CST 2022, time=2022-10-12, status=1, ipAttribution=)]
    2023-08-15 ms7000000431018817 来自天津

    偏重的研究方向：肿瘤;信号通路
    经验分享：打卡 23.8.15投稿

    2

    展开2条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2145528, encodeId=bbb0214552839, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：癌症;LncRNA;机制研究<br>经验分享：期刊效率非常快，送审时邀请了四位审稿人，不到二十天就收到了三个审稿人的意见，加起来比较多，算是大修，让补一些实验，不过我没有都补完。大修给了返修时间是两个月，我是卡点最后一天修回的，十二天后收到了接收的好消息。总的来说，期刊的编辑很负责，效率很高，建议做分子机制研究的可以试一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e68203665, createdName=ms3000001479435505, createdTime=Thu Jun 29 21:02:28 CST 2023, time=2023-06-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2153895, encodeId=19632153895ba, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：耐药<br>经验分享：新鲜出炉的投稿数据分享：<br>6-20投稿，<br>6-29大修，两个审稿人，提了20个问题，需要补实验，给2个月时间大修<br>8-08修回<br>8-21接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Mon Aug 21 17:00:18 CST 2023, time=2023-08-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2129105, encodeId=4d6a212910559, content=请问这篇期刊需要WB未裁剪的膜吗？需要三次数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c1e6397195, createdName=ms1000000465565248, createdTime=Fri Apr 28 20:58:27 CST 2023, time=2023-04-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2130296, encodeId=06a021302968c, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：长链非编码RNA;胃癌<br>经验分享：2023.01.22投稿，2023.2.21三个审稿人大修，其中第一第二个审稿人意见较多，第三个建议修改语言后接收，2023.3.13修回，2023.4.01小修只剩2个审稿人，第一个审稿人跑路，第二审稿人重复提问第一次的三个问题，第三个审稿人建议直接接收，2023.4.12修回，第三个审稿人两三天就上传意见了，第二个审稿人倒是很快同意审稿，但是就不上传意见，至今已经23天了，还在Under reviewer。第二个伊朗的审稿人，一审1个月，二审拖我3周，三审还在拖我。从第一稿开始要求我引用三篇他自己一两分的文章，而且方向根本不符，一直在拖延一直拖延，我搞不明白这是伊朗审稿人的作风吗？我承认自己文章水，但是碰见这样的审稿人真是让人抓狂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f148262722, createdName=ms1000002048633462, createdTime=Fri May 05 18:17:38 CST 2023, time=2023-05-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2152810, encodeId=6bac215281005, content=偏重的研究方向：肿瘤;信号通路<br>经验分享：打卡 23.8.15投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Tue Aug 15 08:45:04 CST 2023, time=2023-08-15, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2120005, encodeId=78892120005f8, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：细胞生物学;基础研究;细胞信号转导<br>经验分享：2022.12.31 投稿 2023.1.21 大修 给了两个月 2023.3.16 12:00 提交返修稿 2023.3.16 17:00 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210411/da80771de7994056b41a9cf7d83c2962/5ab66ed7d0ad45638a7838a3990b1120.jpg, createdBy=97072405099, createdName=12362864m67暂无昵称, createdTime=Thu Mar 16 18:58:49 CST 2023, time=2023-03-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2139426, encodeId=1f102139426f2, content=审稿速度:6.0 | 投稿命中率:5.0<br>经验分享：大神...我被拒三次了。两次是直接拒，还有一篇是大修后拒绝了。<br>感觉该刊水平很高，特别对文章的布局和逻辑性要求很严格，对文字和图片要求也较高。个人认为比较难投，看来我们团队仍需继续努力，争取中一篇!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eobiabkoCXUvOBNyXMalKS3zXem2O3LBjDlmjoq64XhEZBxFyhv1CxL9tlviaMa9okUyKD6iblpiamoDg/132, createdBy=8e402293681, createdName=ms9694374296529568, createdTime=Sat May 27 21:33:31 CST 2023, time=2023-05-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2133876, encodeId=910921338e662, content=杂志官网公布的时间不到一个月。但是我返修目前已经一个月了，还是Under Review？这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c755527092, createdName=smf1993428, createdTime=Mon May 15 10:38:44 CST 2023, time=2023-05-15, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2122806, encodeId=1e5621228066f, content=投稿一个多月，告诉我找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d115608144, createdName=ms2000000959270113, createdTime=Thu Mar 30 19:22:37 CST 2023, time=2023-03-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093349, encodeId=4e632093349e1, content=请问一般with editor多久啊？都一周了还没有消息？会不会被拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b058356108, createdName=ms1000000391690108, createdTime=Wed Oct 12 11:14:27 CST 2022, time=2022-10-12, status=1, ipAttribution=)]
    2023-03-16 12362864m67暂无昵称 来自江西省

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向：细胞生物学;基础研究;细胞信号转导
    经验分享：2022.12.31 投稿 2023.1.21 大修 给了两个月 2023.3.16 12:00 提交返修稿 2023.3.16 17:00 Accepted

    2

    展开2条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2145528, encodeId=bbb0214552839, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：癌症;LncRNA;机制研究<br>经验分享：期刊效率非常快，送审时邀请了四位审稿人，不到二十天就收到了三个审稿人的意见，加起来比较多，算是大修，让补一些实验，不过我没有都补完。大修给了返修时间是两个月，我是卡点最后一天修回的，十二天后收到了接收的好消息。总的来说，期刊的编辑很负责，效率很高，建议做分子机制研究的可以试一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e68203665, createdName=ms3000001479435505, createdTime=Thu Jun 29 21:02:28 CST 2023, time=2023-06-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2153895, encodeId=19632153895ba, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：耐药<br>经验分享：新鲜出炉的投稿数据分享：<br>6-20投稿，<br>6-29大修，两个审稿人，提了20个问题，需要补实验，给2个月时间大修<br>8-08修回<br>8-21接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Mon Aug 21 17:00:18 CST 2023, time=2023-08-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2129105, encodeId=4d6a212910559, content=请问这篇期刊需要WB未裁剪的膜吗？需要三次数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c1e6397195, createdName=ms1000000465565248, createdTime=Fri Apr 28 20:58:27 CST 2023, time=2023-04-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2130296, encodeId=06a021302968c, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：长链非编码RNA;胃癌<br>经验分享：2023.01.22投稿，2023.2.21三个审稿人大修，其中第一第二个审稿人意见较多，第三个建议修改语言后接收，2023.3.13修回，2023.4.01小修只剩2个审稿人，第一个审稿人跑路，第二审稿人重复提问第一次的三个问题，第三个审稿人建议直接接收，2023.4.12修回，第三个审稿人两三天就上传意见了，第二个审稿人倒是很快同意审稿，但是就不上传意见，至今已经23天了，还在Under reviewer。第二个伊朗的审稿人，一审1个月，二审拖我3周，三审还在拖我。从第一稿开始要求我引用三篇他自己一两分的文章，而且方向根本不符，一直在拖延一直拖延，我搞不明白这是伊朗审稿人的作风吗？我承认自己文章水，但是碰见这样的审稿人真是让人抓狂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f148262722, createdName=ms1000002048633462, createdTime=Fri May 05 18:17:38 CST 2023, time=2023-05-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2152810, encodeId=6bac215281005, content=偏重的研究方向：肿瘤;信号通路<br>经验分享：打卡 23.8.15投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Tue Aug 15 08:45:04 CST 2023, time=2023-08-15, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2120005, encodeId=78892120005f8, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：细胞生物学;基础研究;细胞信号转导<br>经验分享：2022.12.31 投稿 2023.1.21 大修 给了两个月 2023.3.16 12:00 提交返修稿 2023.3.16 17:00 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210411/da80771de7994056b41a9cf7d83c2962/5ab66ed7d0ad45638a7838a3990b1120.jpg, createdBy=97072405099, createdName=12362864m67暂无昵称, createdTime=Thu Mar 16 18:58:49 CST 2023, time=2023-03-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2139426, encodeId=1f102139426f2, content=审稿速度:6.0 | 投稿命中率:5.0<br>经验分享：大神...我被拒三次了。两次是直接拒，还有一篇是大修后拒绝了。<br>感觉该刊水平很高，特别对文章的布局和逻辑性要求很严格，对文字和图片要求也较高。个人认为比较难投，看来我们团队仍需继续努力，争取中一篇!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eobiabkoCXUvOBNyXMalKS3zXem2O3LBjDlmjoq64XhEZBxFyhv1CxL9tlviaMa9okUyKD6iblpiamoDg/132, createdBy=8e402293681, createdName=ms9694374296529568, createdTime=Sat May 27 21:33:31 CST 2023, time=2023-05-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2133876, encodeId=910921338e662, content=杂志官网公布的时间不到一个月。但是我返修目前已经一个月了，还是Under Review？这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c755527092, createdName=smf1993428, createdTime=Mon May 15 10:38:44 CST 2023, time=2023-05-15, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2122806, encodeId=1e5621228066f, content=投稿一个多月，告诉我找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d115608144, createdName=ms2000000959270113, createdTime=Thu Mar 30 19:22:37 CST 2023, time=2023-03-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093349, encodeId=4e632093349e1, content=请问一般with editor多久啊？都一周了还没有消息？会不会被拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b058356108, createdName=ms1000000391690108, createdTime=Wed Oct 12 11:14:27 CST 2022, time=2022-10-12, status=1, ipAttribution=)]
    2023-05-27 ms9694374296529568 来自湖北省

    审稿速度:6.0 | 投稿命中率:5.0
    经验分享：大神...我被拒三次了。两次是直接拒，还有一篇是大修后拒绝了。
    感觉该刊水平很高，特别对文章的布局和逻辑性要求很严格，对文字和图片要求也较高。个人认为比较难投，看来我们团队仍需继续努力，争取中一篇!

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2145528, encodeId=bbb0214552839, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：癌症;LncRNA;机制研究<br>经验分享：期刊效率非常快，送审时邀请了四位审稿人，不到二十天就收到了三个审稿人的意见，加起来比较多，算是大修，让补一些实验，不过我没有都补完。大修给了返修时间是两个月，我是卡点最后一天修回的，十二天后收到了接收的好消息。总的来说，期刊的编辑很负责，效率很高，建议做分子机制研究的可以试一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e68203665, createdName=ms3000001479435505, createdTime=Thu Jun 29 21:02:28 CST 2023, time=2023-06-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2153895, encodeId=19632153895ba, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：耐药<br>经验分享：新鲜出炉的投稿数据分享：<br>6-20投稿，<br>6-29大修，两个审稿人，提了20个问题，需要补实验，给2个月时间大修<br>8-08修回<br>8-21接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Mon Aug 21 17:00:18 CST 2023, time=2023-08-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2129105, encodeId=4d6a212910559, content=请问这篇期刊需要WB未裁剪的膜吗？需要三次数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c1e6397195, createdName=ms1000000465565248, createdTime=Fri Apr 28 20:58:27 CST 2023, time=2023-04-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2130296, encodeId=06a021302968c, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：长链非编码RNA;胃癌<br>经验分享：2023.01.22投稿，2023.2.21三个审稿人大修，其中第一第二个审稿人意见较多，第三个建议修改语言后接收，2023.3.13修回，2023.4.01小修只剩2个审稿人，第一个审稿人跑路，第二审稿人重复提问第一次的三个问题，第三个审稿人建议直接接收，2023.4.12修回，第三个审稿人两三天就上传意见了，第二个审稿人倒是很快同意审稿，但是就不上传意见，至今已经23天了，还在Under reviewer。第二个伊朗的审稿人，一审1个月，二审拖我3周，三审还在拖我。从第一稿开始要求我引用三篇他自己一两分的文章，而且方向根本不符，一直在拖延一直拖延，我搞不明白这是伊朗审稿人的作风吗？我承认自己文章水，但是碰见这样的审稿人真是让人抓狂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f148262722, createdName=ms1000002048633462, createdTime=Fri May 05 18:17:38 CST 2023, time=2023-05-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2152810, encodeId=6bac215281005, content=偏重的研究方向：肿瘤;信号通路<br>经验分享：打卡 23.8.15投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Tue Aug 15 08:45:04 CST 2023, time=2023-08-15, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2120005, encodeId=78892120005f8, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：细胞生物学;基础研究;细胞信号转导<br>经验分享：2022.12.31 投稿 2023.1.21 大修 给了两个月 2023.3.16 12:00 提交返修稿 2023.3.16 17:00 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210411/da80771de7994056b41a9cf7d83c2962/5ab66ed7d0ad45638a7838a3990b1120.jpg, createdBy=97072405099, createdName=12362864m67暂无昵称, createdTime=Thu Mar 16 18:58:49 CST 2023, time=2023-03-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2139426, encodeId=1f102139426f2, content=审稿速度:6.0 | 投稿命中率:5.0<br>经验分享：大神...我被拒三次了。两次是直接拒，还有一篇是大修后拒绝了。<br>感觉该刊水平很高，特别对文章的布局和逻辑性要求很严格，对文字和图片要求也较高。个人认为比较难投，看来我们团队仍需继续努力，争取中一篇!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eobiabkoCXUvOBNyXMalKS3zXem2O3LBjDlmjoq64XhEZBxFyhv1CxL9tlviaMa9okUyKD6iblpiamoDg/132, createdBy=8e402293681, createdName=ms9694374296529568, createdTime=Sat May 27 21:33:31 CST 2023, time=2023-05-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2133876, encodeId=910921338e662, content=杂志官网公布的时间不到一个月。但是我返修目前已经一个月了，还是Under Review？这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c755527092, createdName=smf1993428, createdTime=Mon May 15 10:38:44 CST 2023, time=2023-05-15, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2122806, encodeId=1e5621228066f, content=投稿一个多月，告诉我找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d115608144, createdName=ms2000000959270113, createdTime=Thu Mar 30 19:22:37 CST 2023, time=2023-03-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093349, encodeId=4e632093349e1, content=请问一般with editor多久啊？都一周了还没有消息？会不会被拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b058356108, createdName=ms1000000391690108, createdTime=Wed Oct 12 11:14:27 CST 2022, time=2022-10-12, status=1, ipAttribution=)]
    2023-05-15 smf1993428 来自河北省

    杂志官网公布的时间不到一个月。但是我返修目前已经一个月了，还是Under Review？这是什么情况？

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2145528, encodeId=bbb0214552839, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：癌症;LncRNA;机制研究<br>经验分享：期刊效率非常快，送审时邀请了四位审稿人，不到二十天就收到了三个审稿人的意见，加起来比较多，算是大修，让补一些实验，不过我没有都补完。大修给了返修时间是两个月，我是卡点最后一天修回的，十二天后收到了接收的好消息。总的来说，期刊的编辑很负责，效率很高，建议做分子机制研究的可以试一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e68203665, createdName=ms3000001479435505, createdTime=Thu Jun 29 21:02:28 CST 2023, time=2023-06-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2153895, encodeId=19632153895ba, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：耐药<br>经验分享：新鲜出炉的投稿数据分享：<br>6-20投稿，<br>6-29大修，两个审稿人，提了20个问题，需要补实验，给2个月时间大修<br>8-08修回<br>8-21接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Mon Aug 21 17:00:18 CST 2023, time=2023-08-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2129105, encodeId=4d6a212910559, content=请问这篇期刊需要WB未裁剪的膜吗？需要三次数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c1e6397195, createdName=ms1000000465565248, createdTime=Fri Apr 28 20:58:27 CST 2023, time=2023-04-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2130296, encodeId=06a021302968c, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：长链非编码RNA;胃癌<br>经验分享：2023.01.22投稿，2023.2.21三个审稿人大修，其中第一第二个审稿人意见较多，第三个建议修改语言后接收，2023.3.13修回，2023.4.01小修只剩2个审稿人，第一个审稿人跑路，第二审稿人重复提问第一次的三个问题，第三个审稿人建议直接接收，2023.4.12修回，第三个审稿人两三天就上传意见了，第二个审稿人倒是很快同意审稿，但是就不上传意见，至今已经23天了，还在Under reviewer。第二个伊朗的审稿人，一审1个月，二审拖我3周，三审还在拖我。从第一稿开始要求我引用三篇他自己一两分的文章，而且方向根本不符，一直在拖延一直拖延，我搞不明白这是伊朗审稿人的作风吗？我承认自己文章水，但是碰见这样的审稿人真是让人抓狂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f148262722, createdName=ms1000002048633462, createdTime=Fri May 05 18:17:38 CST 2023, time=2023-05-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2152810, encodeId=6bac215281005, content=偏重的研究方向：肿瘤;信号通路<br>经验分享：打卡 23.8.15投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Tue Aug 15 08:45:04 CST 2023, time=2023-08-15, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2120005, encodeId=78892120005f8, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：细胞生物学;基础研究;细胞信号转导<br>经验分享：2022.12.31 投稿 2023.1.21 大修 给了两个月 2023.3.16 12:00 提交返修稿 2023.3.16 17:00 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210411/da80771de7994056b41a9cf7d83c2962/5ab66ed7d0ad45638a7838a3990b1120.jpg, createdBy=97072405099, createdName=12362864m67暂无昵称, createdTime=Thu Mar 16 18:58:49 CST 2023, time=2023-03-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2139426, encodeId=1f102139426f2, content=审稿速度:6.0 | 投稿命中率:5.0<br>经验分享：大神...我被拒三次了。两次是直接拒，还有一篇是大修后拒绝了。<br>感觉该刊水平很高，特别对文章的布局和逻辑性要求很严格，对文字和图片要求也较高。个人认为比较难投，看来我们团队仍需继续努力，争取中一篇!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eobiabkoCXUvOBNyXMalKS3zXem2O3LBjDlmjoq64XhEZBxFyhv1CxL9tlviaMa9okUyKD6iblpiamoDg/132, createdBy=8e402293681, createdName=ms9694374296529568, createdTime=Sat May 27 21:33:31 CST 2023, time=2023-05-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2133876, encodeId=910921338e662, content=杂志官网公布的时间不到一个月。但是我返修目前已经一个月了，还是Under Review？这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c755527092, createdName=smf1993428, createdTime=Mon May 15 10:38:44 CST 2023, time=2023-05-15, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2122806, encodeId=1e5621228066f, content=投稿一个多月，告诉我找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d115608144, createdName=ms2000000959270113, createdTime=Thu Mar 30 19:22:37 CST 2023, time=2023-03-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093349, encodeId=4e632093349e1, content=请问一般with editor多久啊？都一周了还没有消息？会不会被拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b058356108, createdName=ms1000000391690108, createdTime=Wed Oct 12 11:14:27 CST 2022, time=2022-10-12, status=1, ipAttribution=)]
    2023-03-30 ms2000000959270113 来自广东省

    投稿一个多月，告诉我找不到审稿人

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2145528, encodeId=bbb0214552839, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：癌症;LncRNA;机制研究<br>经验分享：期刊效率非常快，送审时邀请了四位审稿人，不到二十天就收到了三个审稿人的意见，加起来比较多，算是大修，让补一些实验，不过我没有都补完。大修给了返修时间是两个月，我是卡点最后一天修回的，十二天后收到了接收的好消息。总的来说，期刊的编辑很负责，效率很高，建议做分子机制研究的可以试一试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07e68203665, createdName=ms3000001479435505, createdTime=Thu Jun 29 21:02:28 CST 2023, time=2023-06-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2153895, encodeId=19632153895ba, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：耐药<br>经验分享：新鲜出炉的投稿数据分享：<br>6-20投稿，<br>6-29大修，两个审稿人，提了20个问题，需要补实验，给2个月时间大修<br>8-08修回<br>8-21接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=34a12034709, createdName=1891e859aem, createdTime=Mon Aug 21 17:00:18 CST 2023, time=2023-08-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2129105, encodeId=4d6a212910559, content=请问这篇期刊需要WB未裁剪的膜吗？需要三次数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c1e6397195, createdName=ms1000000465565248, createdTime=Fri Apr 28 20:58:27 CST 2023, time=2023-04-28, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2130296, encodeId=06a021302968c, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向：长链非编码RNA;胃癌<br>经验分享：2023.01.22投稿，2023.2.21三个审稿人大修，其中第一第二个审稿人意见较多，第三个建议修改语言后接收，2023.3.13修回，2023.4.01小修只剩2个审稿人，第一个审稿人跑路，第二审稿人重复提问第一次的三个问题，第三个审稿人建议直接接收，2023.4.12修回，第三个审稿人两三天就上传意见了，第二个审稿人倒是很快同意审稿，但是就不上传意见，至今已经23天了，还在Under reviewer。第二个伊朗的审稿人，一审1个月，二审拖我3周，三审还在拖我。从第一稿开始要求我引用三篇他自己一两分的文章，而且方向根本不符，一直在拖延一直拖延，我搞不明白这是伊朗审稿人的作风吗？我承认自己文章水，但是碰见这样的审稿人真是让人抓狂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f148262722, createdName=ms1000002048633462, createdTime=Fri May 05 18:17:38 CST 2023, time=2023-05-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2152810, encodeId=6bac215281005, content=偏重的研究方向：肿瘤;信号通路<br>经验分享：打卡 23.8.15投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e52b8470971, createdName=ms7000000431018817, createdTime=Tue Aug 15 08:45:04 CST 2023, time=2023-08-15, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2120005, encodeId=78892120005f8, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：细胞生物学;基础研究;细胞信号转导<br>经验分享：2022.12.31 投稿 2023.1.21 大修 给了两个月 2023.3.16 12:00 提交返修稿 2023.3.16 17:00 Accepted, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210411/da80771de7994056b41a9cf7d83c2962/5ab66ed7d0ad45638a7838a3990b1120.jpg, createdBy=97072405099, createdName=12362864m67暂无昵称, createdTime=Thu Mar 16 18:58:49 CST 2023, time=2023-03-16, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2139426, encodeId=1f102139426f2, content=审稿速度:6.0 | 投稿命中率:5.0<br>经验分享：大神...我被拒三次了。两次是直接拒，还有一篇是大修后拒绝了。<br>感觉该刊水平很高，特别对文章的布局和逻辑性要求很严格，对文字和图片要求也较高。个人认为比较难投，看来我们团队仍需继续努力，争取中一篇!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eobiabkoCXUvOBNyXMalKS3zXem2O3LBjDlmjoq64XhEZBxFyhv1CxL9tlviaMa9okUyKD6iblpiamoDg/132, createdBy=8e402293681, createdName=ms9694374296529568, createdTime=Sat May 27 21:33:31 CST 2023, time=2023-05-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2133876, encodeId=910921338e662, content=杂志官网公布的时间不到一个月。但是我返修目前已经一个月了，还是Under Review？这是什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c755527092, createdName=smf1993428, createdTime=Mon May 15 10:38:44 CST 2023, time=2023-05-15, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2122806, encodeId=1e5621228066f, content=投稿一个多月，告诉我找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d115608144, createdName=ms2000000959270113, createdTime=Thu Mar 30 19:22:37 CST 2023, time=2023-03-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2093349, encodeId=4e632093349e1, content=请问一般with editor多久啊？都一周了还没有消息？会不会被拒？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b058356108, createdName=ms1000000391690108, createdTime=Wed Oct 12 11:14:27 CST 2022, time=2022-10-12, status=1, ipAttribution=)]
    2022-10-12 ms1000000391690108

    请问一般with editor多久啊？都一周了还没有消息？会不会被拒？

    4

    展开4条回复
共168条页码: 2/17页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分